.jpg "Stephen Hahn"){kind=small}
Brett Giroir
Search results
Jun 15, 2021 · Stephen Hahn, a former commissioner of the Food and Drug Administration (FDA), is set to serve as a chief medical officer at the venture capital firm that launched Moderna, according to a...
Jun 14, 2021 · Stephen Hahn, M.D. (FDA) But now, Hahn will head for another high pressure environment: biotech investing. He is now joining Flagship, the venture fund that birthed Moderna, the very company...
- Kyle Lahucik
In 2021, he became chief medical officer at Flagship Pioneering, the venture capital firm that launched Moderna . Education. Hahn received a BA in Biology from Rice University in 1980, and an MD from Temple University in 1984. [2] .
Jun 15, 2021 · Former FDA chief Hahn defends his jump to Flagship Pioneering, the firm behind Moderna. By Kate Sheridan. Reprints. Former FDA Commissioner Stephen Hahn Bill Clark/CQ Roll Call via AP. W...
Dec 16, 2020 · An oncologist by training, Hahn was barely a month into the job at the FDA when the first COVID-19 case arrived in the United States and thrust him into the center of a generation-defining crisis. It was certainly not how he anticipated he'd spend his entire tenure.
Nov 1, 2023 · On 18 December 2020, under the leadership of FDA commissioner Stephen Hahn, the FDA granted a world first authorisation to Moderna’s covid vaccine, mRNA-1273. Six months later, after resigning his post with the transition to the Biden administration, Hahn joined Flagship Pioneering—“the venture fund that birthed Moderna.” 16
Jun 15, 2021 · Previously a top executive at M.D. Anderson Cancer Center, Hahn headed the FDA during its high-pressure review of COVID-19 drugs and vaccines in 2020, including Gilead’s antiviral treatment Veklury and vaccines from Moderna and Pfizer. The Washington Post first reported he would join Flagship.
